San Carlos, CA, United States of America

Danforth Miller

USPTO Granted Patents = 8 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 24(Granted Patents)

Company Filing History:

Years Active: 2008-2020

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10745473 - Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules (2020-08-18),

2. 10744098 - Spray-dried solid-in-oil-in-water dispersions for inhalation of active pharmaceutical ingredients (2020-08-18),

3. 10000561 - Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules (2018-06-19),

4. 9050267 - Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases (2015-06-09),

5. 8668934 - Pharmaceutical formulation comprising a water-insoluble active agent (2014-03-11),

6. 8513204 - Compositions comprising amphotericin B, mehods and systems (2013-08-20),

7. 7862834 - Pharmaceutical formulation comprising a water-insoluble active agent (2011-01-04),

8. 7326691 - Compositions comprising amphotericin B, methods, and systems (2008-02-05),

Title: Danforth Miller: Innovator in Pharmaceutical Technologies

Introduction

Danforth Miller is a notable inventor based in San Carlos, CA (US), recognized for his contributions to pharmaceutical technologies. He holds a total of 8 patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Miller's latest patents include groundbreaking work on "Spray-dried solid-in-oil-in-water dispersions for inhalation of active pharmaceutical ingredients." This invention relates to particulate agents and compositions designed for inhalation, along with methods for preparing these agents. The process involves creating an emulsion by combining an oil phase dispersion of hydrophobic seed particles with an aqueous dispersion that includes an emulsifier and stabilizer. The resulting feedstock is homogenized to form encapsulated particles, which are then spray-dried to produce coated particles featuring a porous shell over a core of hydrophobic seed particles.

Another significant patent is focused on "Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules." This invention provides specific molecules, such as antibodies or antibody fragments, that bind to TSLP. It also includes compositions containing these molecules and outlines methods for their production and application.

Career Highlights

Throughout his career, Danforth Miller has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Nektar Therapeutics. His experience in these organizations has contributed to his expertise in developing innovative solutions for complex medical challenges.

Collaborations

Miller has collaborated with talented individuals in his field, including Daniel Huang and David Lechuga-Ballesteros. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Danforth Miller's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of innovative medical solutions that enhance patient care.

This text is generated by artificial intelligence and may not be accurate.